课题基金 / 基金详情

Kinin B1 receptor as a key target in the treatment of hypertension and insulin resistance

Kinin B1 receptor as a key target in the treatment of hypertension and insulin resistance
激肽 B1 受体作为治疗高血压和胰岛素抵抗的关键靶点
批准号:
238159
负责人:
Couture Rjean
金额:
$46.69万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-09-01 至 2016-09-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We showed that treatments with antioxidants or inhibitors of B1 receptor (B1R) for kinins (local hormone and brain mediator) reversed hypertension and diabetes abnormalities in rat models. The B1R is absent in healthy subjects and its occurrence is the si
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金